Implantable sensors for glucose monitoring are the first step towards the development of an implantable closed-loop diabetes control system. Although significant advances in the designs and chemistries employed to prepare intravascular and subcutaneous devices have been achieved, the biological responses can have a dramatic impact on the analytical accuracy of such probes. With a view to assisting the effective design of such devices for assuring clinical performance, the causes of implantable glucose sensor failure have been investigated by means of Fault Tree Analysis (FTA) relying on fuzzy reasoning to account for uncertainty. The approach suggested may contribute significantly to the self-optimisation of the measuring equipment from one generation to the next as it supports the flexible, ad hoc, and tailor made sensor development, thus potentiating the progress of epidemics from statistics to individualisation.
Introduction
Intensive treatment and close diabetes mellitus monitoring can prevent progression of long-term disease complications, such as retinopathy, nephropathy, and neuropathy. Accurate and systematic glucose monitoring is a key element for allowing patients to keep their glucose levels under control and for providing physicians with a more correct and detailed picture of the disease. The available self-monitoring devices, based on discrete monitoring measurements, apart from causing patients' discomfort, do not allow an overall, clear and in-depth view of the actual glycaemic status, especially in type I diabetics, where glycaemia may undergo rapid changes [1] . A continuous and fully automated subcutaneous glucose monitoring device would most certainly improve diabetic control, especially in less-apt individuals (young, elderly, mentally-challenged, etc.). It could also provide valuable information to R&D regarding in vivo kinetic parameters after lunch, during sleep or exercise, as a first step towards a completely closed-loop control system that automatically monitors and maintains euglycaemia (artificial pancreas).
Numerous implantable miniaturized sensors have been developed, mostly on an electroenzymatic approach: using the oxidation of glucose by glucose oxidase, the produced hydrogen peroxide is measured either amperometrically or potentiometrically. Most sensors use a platinum cathode and a silver anode to form part of an electric circuit in which hydrogen peroxide is electrolyzed; the current through the circuit provides a measure of the hydrogen peroxide concentration, and hence of the glucose concentration in the vicinity of the sensor. For subcutaneous implantation, the sensors are designed with standard integrated circuit (IC) micro-fabrication processes; all signal processing can be accomplished on-board the chip, and the entire package is not more than a few square millimeters in size. Subcutaneous implantation of the sensors could be accomplished as an outpatient procedure with minor discomfort to the patient.
Unfortunately, the response of these devices undergoes a significant decrease (accompanied by a corresponding noise increase) when exposed to the biological environment, attributed to (i) biocompatibility issues: inflammation, fibrosis, scar formation, clot formation in blood vessels, or other tissue reactions [2, 3] , (ii) biofouling: excessive protein deposition (clogging of the membrane pores with proteins resulting in a decrease or cessation of the flow of molecules to the sensor) [4] [5] [6] , (iii) corrosion: decreased chemical resistance (the tissue environment can be remarkably corrosive) [7, 8] , (iv) the inherent sensor pitfalls: problems associate with the biorecognition/transducer interface [7, 8] , and (v) biocorrelation issues: the in vivo sensor performance differs significantly from its operation ex vivo, usually expressed as a rapid and significant sensor drift [9] .
In view of (a) the inter-disciplinary and effectively diverse nature of the subject, (b) the complexity presented by the specific application and (c) the severity and prospects of the application, these devices require inevitably an intelligent system for real-time fault detection and fault compensation, an area which has not received yet much attention. The real-time response of such a system is imperative when considering that misleading measurements may enable inappropriate drug delivery that may stimulate vicious feed-back cycles, threatening to the life of the patient (e.g. severe hypoglycaemic episodes).
The identification of the possible sensor fault modes and their symptoms is a prerequisite for constructing such a system, requiring in-depth knowledge of sensor's design and operation, both from the electrochemical and the physiological/biochemical point of view. The most usual and critical fault mode in subcutaneous biosensors is sensitivity drift, which results either to an inaccurate measurement or to a dead sensor [7] . The environment within which the sensor operates, involving complex multi-component chemical interactions within multi-phase microstructures, increases uncertainty manifold since there could be (and usually are) many influences acting simultaneously or consecutively, masking, partially or totally, the identification of the problem source. There have been several attempts for understanding the possible failure mechanisms responsible for the poor in vivo performance of subcutaneously implanted glucose sensors, but still there is no clinical concept available and more insight is required in the physiological processes at the sensor-tissue interface. Limited information and high uncertainty has been successfully handled in several biomedical cases with fuzzy logic [10, 11] . Fuzzy set theory provides a way to use imprecise and uncertain information generated by the environmental system and the human judgment in a satisfactory way, in cases where absolute criteria should be avoided and the intuitive aspects of the experts' judgment should be preserved.
The work presented herein investigates the causes of implanted biosensor sensitivity reduction by means of Fault Tree Analysis (FTA), using the information provided by the biosensor components, the surrounding tissue and their intra/inter-relations on both, the surface-and the deep-knowledge level, simulating an expert system, where the tree (dendritic) structure (with the corresponding to each node appropriate confirmation tests and remedial proposals/advices) serves as the Knowledge Base (KB) and the fuzzy rules based decision mechanism on aetiology is the inference engine.
Methodology
The methodology adopted relies mainly on the design and the development of a hierarchical structure capable to perform Fault Tree Analysis (FTA) within a framework incorporating (a) the trunk of the SNR-decrease fault tree (i.e., the content part of the fault analysis), and (b) a mechanism of (i) assigning fuzzy partition of the space of the variables represented by each tree node and (ii) setting/revising of fuzzy rules used as an inference engine (i.e., the formal part of fault analysis).
The tree is structured in a top-down direction by deduction, involving the identification of the events or series of events that directly contribute to sensor malfunction, the immediate causes of these events and so forth, until the ultimate or final causes are identified. Conversely, a revision can be made by induction, after proper information has been collected. This dialectic trade-off between deduction and induction brings the tree design closer to scientific logic, permitting the introduction of deeper knowledge into the surface or experiential knowledge level characterizing FTA.
Once the final form (in content and architecture) of the fault tree has been agreed upon, the partitioning of the space of variables and the determination of the fuzzy rules serving as an inference engine for diagnosis can been achieved by using experts' opinion through a modified 4-stage Delphi method [7, 8] . Running the fuzzy FTA bottom-up, using first the combination of the final events that contributes mostly (as per strength and frequency) to the top event, a crisp number is calculated for the latter and compared to the specified threshold.
Likewise, based on a nested loop mechanism, the most influential combination responsible for the top event is experimentally confirmed and, if possible, rectified; otherwise the next combination is examined, and so on until the value of the top event reaches the threshold. The selectivity of research is thereby enhanced considerably by concentrating attention to the most influential variables, consequently saving resources and increasing research value. A measure of the success of the corrective activity is given by the crisp value estimated for the top event, which assumes rather the character of the 'best achievable' than 'analytically correct', thereby providing the background necessary to proceed with wide applicability.
Sensor sensitivity drift
Sensor sensitivity is a controversial term. It usually implies the slope of the calibration curve in the vicinity of the expected real measurement, i.e., a function of analyte concentration [12] ; as such it can be defined as either the minimum input signal required to produced a specific output, given a certain signal-tonoise ratio, or as the ratio of the signal output for a given concentration to the signal obtained for an adjacent concentration value (C±1). This property is very crucial, especially towards the limit of detection where hypoglycaemic episodes should be identified as soon as possible in order for the patient to receive insulin, as well as for the detection of abrupt glucose changes [2] .
A sensitivity drift (set as top event) involves either a responsivity decrease, i.e., a decrease of the output signal in response to input [7, 8] , or a modification of the analyte flux kinetics (the pumping of glucose from the interstitial fluid in the sensor) [13] , or incorrect calibration, especially in in vivo-ex vivo correlations [9] . The intermediate events that lead to these second-level events can be revealed when considering the design, the operation and the environment around and within the sensor. A sample of the background tree is presented in fig. 1 , whereas the description of its nodes is as follows: (1.1) decrease of responsivity; (1.2) modification of analyte flux kinetics; (1.3) poor in vivo/in vitro correlation; (1.1.1) inhibition of enzymatic reaction; (1. Figure 1 : Sample of the fault tree investigating the causes of sensitivity drift in implantable sensors: the qualitative upper part of the tree constituting the content part of the methodological framework (the formal being the mechanism of setting/revising the fuzzy rules).
(1. Each tree node has been quantified using ranges of values that could be described by the linguistic terms (fuzzy sets) low, medium, and high. The degree, or weighting, that any value belongs to a fuzzy set is represented by the membership function; over their domain of interest, the membership functions take a value between 0 and 1; each term is schematically presented as a triangle, peaking at the value that the node-event is most commonly found (membership function 1). Using the inference engine, the basal events are entered as crisp numbers (values) and their directly intermediate events (output) are produced as fuzzy sets; these, after defuzzification, they are re-entered as crisp values, and so-forth until a crisp value is produced for the top-event.
Implementation
The methodology described above has been implemented in node 1.2.1.1.2.2 (branch A of fig. 1 ), 'thrombus formation on the sensor surface', one of the most commonly encountered problem in implanted materials [5] : the thrombus covers the sensor surface inhibiting glucose diffusion ( fig. 2) The reactions of the body to an implant crucially depend on the surface of the implant [4] , especially the chemical situation present at the surface [5] , the surface texture [4] , the local flow conditions [13] generally known, that 'increased platelet adhesion, activation and aggregation' (node A.1) on implant surfaces exposed precede the formation of the thrombus [14] . Despite, however, the directly related physiological reasons that contribute to the top even, implant failure can be triggered by phenomenologically unrelated reasons, as calcium or vitamin C intake [15, 16] The threshold value set for event A is 20%, as proven suitable for retaining much of sensor's functionality. The problem investigated refers mainly to the effect of calcium intake by the subject upon the sensor performance, considering also other parallel physiological processes. Nine scenarios have been tested (Table 1) aiming at examining all possible combinations and influences. The results have shown that at any value of the basal event (cases 1-3), event A is well below the tolerance value, provided that all other inputs are kept low. There is a slight increase in event A when the calcium stores are activated (node A.2. 1 ). At cases 6-8, even when histamine levels are kept at medium values, the estimated values are above the set threshold. It can be thus concluded that, after implantation, the cholesterol and histamine levels should be carefully monitored at a regular basis in order to prevent thrombogenic activity.
Discussion and conclusions
The method presented herein serves effectively to localize the causes of sensor drift in implantable biosensors under conditions of uncertainty. When coupled to fuzzy reasoning, it provides a tool for internal diagnostics and fault compensation under nearly real-time conditions. The FTA approach suggested enhances selectivity of R&D effort by concentrating attention to the most influential variables, consequently saving valuable resources (time, effort, money, scientific equipment, highly skilled labour). When investigating biosensor failure during in vivo operation, feasibility is enhanced by assigning threshold values of the tolerability of the device to the top event. In this way, the required distinction between critical and non-critical status of the top event can be sharper to improve sensor validation, an issue of great significance, especially for biomedical applications intended for everyday, wide-spread self-monitoring uses. The approach suggested may contribute significantly to the selfoptimisation of the measuring equipment from one generation to the next as it supports the flexible ad hoc tailor made development, thus potentiating the progress of epidemics from statistics to individualisation.
